Legislation · Canada (Federal) · Federal
C-224 — An Act to amend the Food and Drugs Act (natural health products)
Clarion tracks C-224 before Canada (Federal) — its status, sponsor, plain-language summary, and every stage it moves through, each cited to the official record and refreshed each morning.
- Status
- At Consideration In Committee In The House Of Commons
- Sponsor
- Blaine Calkins
- Introduced
- 2025-09-18
- Session
- 45-1
What it does
AI plain-language summary of the official text.
Bill C-224 is a Private Member's Bill introduced in the 45th Parliament that seeks to amend the Food and Drugs Act with respect to natural health products. The bill passed second reading in the House of Commons and is currently under study by a committee. The specific changes proposed would affect how natural health products are regulated under that Act.
Passage outlook
Contested because it's a private member's bill (which rarely passes), it's at committee.
Historically 0–5% of comparable federal bills became law (base rate 4%, n=1067).
If this private member's bill would create new spending, it needs a Royal Recommendation (Cabinet only) — without one, passage is effectively nil.
A private member's bill's fate hinges on its position in the Order of Precedence (a random draw) — bills low on the list often run out of calendar time.
A transparent, rule-based outlook from bill type, stage, and verified government standing — not a guaranteed prediction.
The weekly read
Get The Dispatch in your inbox
One email a week: the bills gaining momentum, who's lobbying whom, and the passage odds that moved — across Parliament, the legislatures, and city hall. Free, in English or French.
Track C-224 — and everything like it
Set a topic, and Clarion grades every new bill, debate, and lobbying filing to your files — with a calibrated passage forecast and an AI clerk that answers from the record and cites it.